Maryland Oncology Hematology- Site Number : 8400038 is a clinical research site located in Washington D.C., District of Columbia, United States 20017.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Maryland Oncology Hematology- Site Number : 8400038 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Plasma Cell Myeloma Refractory.
Sponsors: Sanofi.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Maryland Oncology Hematology- Site Number : 8400038 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Maryland Oncology Hematology- Site Number : 8400038 has 1 clinical trials on record, with 1 currently active. Their work covers Plasma Cell Myeloma Refractory.
Maryland Oncology Hematology- Site Number : 8400038 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.